T. van Staa

First name
T.
Middle name
P.
Last name
van Staa
Rietbrock, S., Plumb, J. M., Gallagher, A. M., & van Staa, T. P. (2009). How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database. Thromb Haemost.
View
van Staa, T. P., Leufkens, H. G., Zhang, B., & Smeeth, L. (2009). A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example. PLoS Med. http://doi.org/10.1371/journal.pmed.1000194
View
de Vries, F., Cooper, A. L., Cockle, S. M., van Staa, T. P., & Cooper, C. (2009). Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. http://doi.org/10.1007/s00198-009-0891-4
View
Zhang, B., de Vries, F., Setakis, E., & van Staa, T. P. (2009). The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database. J Hypertens. http://doi.org/10.1097/HJH.0b013e32832af68d
View
de Vries, F., Setakis, E., Zhang, B., & van Staa, T. P. (2010). Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD. Eur Respir J. http://doi.org/10.1183/09031936.00124209
View
Gallagher, A. M., Setakis, E., Plumb, J. M., Clemens, A., & van Staa, T. P. (2011). Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. http://doi.org/10.1160/th11-05-0353
View
Gallagher, A. M., Smeeth, L., Seabroke, S., Leufkens, H. G., & van Staa, T. P. (2011). Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. PLoS One. http://doi.org/10.1371/journal.pone.0028157
View
de Vries, F., Setakis, E., & van Staa, T. P. (2010). Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2010.03705.x
View
Boggon, R., van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A., et al. (2011). Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction\textendasha hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. http://doi.org/10.1093/eurheartj/ehr340
View
van Staa, T. P., Setakis, E., Di Tanna, G. L., Lane, D. A., & . Y. Lip, G. (2011). A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost. http://doi.org/10.1111/j.1538-7836.2010.04085.x
View